Profile photo Tom Snijders

Tom Snijders

Assistant Professor - medical

Strategic program(s):

Biography

T.J. (Tom) Snijders, PhD, completed his medical studies and his Neurology residency in the UMC Utrecht. During his training, he obtained a PhD-degree in the field of chronic pain medicine. He sub-specialized in Neuro-oncology during his residency.

Since 2011, he works as a neurologist and assistant professor in the UMC Utrecht. His practice encompasses all aspects of neuro-oncological patient care. His scientific work focuses on primary brain tumors, specifically gliomas. He is the co-coordinator, with prof. Elly Hol, of the Disease Area Neuro-oncology of the UMC Utrecht Brain Center.  He is co-supervisor of 5 completed or ongoing PhD-trajectories. He is also involved in providing and evaluating experimental treatments (international clinical trials) in the UMC Utrecht.

Research interests:

  • Validation and innovation of imaging techniques for brain tumors, including MRI-scans and PET-scans
  • Pseudoprogression in glioma and other brain tumors
  • Cognitive symptoms in glioma patients
  • Epilepsy due to brain tumors
  • Liquid biopsy in primary brain tumors
  • Focused Ultrasound and blood-brain-barrier disruption for brain tumor treatment
  • The multidisciplinary Team Neuro-Oncology of the UMC Utrecht aims to provide patients with the most recent innovative (experimental) treatments for brain tumors as part of clinical studies.

Research groups

Clinical and translational neuro-oncology

Research aim

We aim to improve treatments and clinical outcomes of patients with gliomas and other brain tumors, by combining expertise from oncobiology, neuropsychology, imaging, surgical & clinical neurology, and palliative care.

Go to group

Recent publications

T2-FLAIR Mismatch: An Imaging Biomarker for Children's MYB/MYBL1-Altered Diffuse Astrocytoma or Angiocentric Glioma. E A van Maren, J W Dankbaar, P Wesseling, S Plasschaert, A Muhlebner, E W Hoving, P A Robe, T J Snijders, R Hoogendijk, M E G Kranendonk, M H Lequin
AJNR. American journal of neuroradiology, 2024, vol. 45, p.747-752
Focused Ultrasound-Enhanced Liquid Biopsy Akke Bakker, Anna E Ixkes, Hema Venugopal, Mario G Ries, Nathalie S M Lak, Filip Y F L de Vos, Dannis G van Vuurden, Tom J Snijders
Cancers, 2024, vol. 16, p.1-15
Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation L P Priesterbach-Ackley, F Cordier, P de Witt Hamer, T J Snijders, P A Robe, B Küsters, W W J de Leng, W F A den Dunnen, D Brandsma, C Jansen, P Wesseling, A Muhlebner
Acta Neuropathologica, 2024, vol. 148
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide Christina Maria Flies, Michel Friedrich, Philipp Lohmann, Karin Alida van Garderen, Marion Smits, Joerg-Christian Tonn, Michael Weller, Norbert Galldiks, Tom Jan Snijders
Neuro-oncology, 2024, vol. 26, p.902-910
The Differentiation between Progressive Disease and Treatment-Induced Effects with Perfusion-Weighted Arterial Spin-Labeling in High-Grade Gliomas Christina Maria Flies, Tom Jan Snijders, Beverly Iendra De Leeuw, Emiel Alexander van Maren, Bart Jean Pieter Kersten, Joost Jacobus Cornelis Verhoeff, Filip Yves Francine De Vos, Pierre Alain Robe, Jeroen Hendrikse, Jan Willem Dankbaar
AJNR. American journal of neuroradiology, 2024, vol. 45, p.920-926
Results from a phase I study of 4-l-[131I]iodo-phenylalanine ([131I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1) Josef Pichler, Tatjana Traub-Weidinger, Kurt Spiegl, Larisa Imamovic, Arthur J.A.T. Braat, Tom J. Snijders, Joost J.C. Verhoeff, Patrick Flamen, Libuse Tauchmanova, Colin Hayward, Andreas Kluge
Neuro-oncology advances, 2024, vol. 6